Pricing and trading are expected within days. Watch for the final offering price and opening trade. The cash infusion likely extends the company's runway, but the substantial dilution may pressure the stock post-offering. Monitor for any underwriter price support and the company's use-of-proceeds disclosure in the final prospectus.
Price Chart
Executive Summary
The SEC declared Regentis Biomaterials' F-1 registration statement effective on July 13, 2026, clearing the way for a firm-commitment offering of 3,333,334 ordinary shares (plus 500,000 over-allotment shares) at an assumed price of $3.00 per share. The IPO will raise approximately $10 million in gross proceeds for the $24M market cap company, providing critical funding but diluting existing shareholders by roughly 42%.
Key Facts
- Effectiveness date: July 13, 2026
- Firm-commitment offering of 3,333,334 ordinary shares at assumed $3.00 per share
- Over-allotment option for up to 500,000 additional shares (15% of the offering)
- Underwriter: ThinkEquity LLC
- Gross proceeds to company: approximately $10 million (assuming full exercise of over-allotment)
- Offering represents roughly 42% dilution based on current $24M market cap
Financial Impact
Gross proceeds of approximately $10 million from the offering; dilution of roughly 42% to existing shareholders at the assumed $3.00 offering price
Risk Factors
- Significant dilution of ~42% pressures near-term share price
- Over-allotment option could add further dilution if exercised
- Post-IPO lock-up expiration may create additional selling pressure
- Company may use proceeds for R&D; no near-term profitability expected
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (RGNT) — Batch item 1 | 9999999995-26-002284 |
| Document: 9999999995-26-002284-index.html | 9999999995-26-002284 |
| Document: 9999999995-26-002284.txt | 9999999995-26-002284 |
| EFFECT Filing (RGNT) — Batch item 4 | 9999999995-26-002284 |
| Document: 9999999995-26-002284-index.html | 9999999995-26-002284 |
| Document: 9999999995-26-002284.txt | 9999999995-26-002284 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.63 | awaiting T+20 | — | $1.26 (−22.46%) |
Sep 23, 2026 4w ago | EFFECT | $2.10 $1.49 | ▼ −29.05% | ▼ −29.74% | $1.26 (−40.00%) |
Jul 20, 2026 14w ago | 6-K | $2.00 $2.04 | ▲ +2.00% | ▼ −2.12% | $1.26 (−37.00%) |
Jul 15, 2026 14w ago | 6-K | $2.43 $1.94 | ▼ −20.16% | ▼ −22.51% | $1.26 (−48.15%) |
Jul 14, 2026 14w ago | EFFECT | $2.54 $1.84 | ▼ −27.56% | ▼ −30.05% | $1.26 (−50.39%) |
Jun 15, 2026 19w ago | 6-K | $9.40 $2.43 | ▲ +74.15% | ▲ +74.15% | $1.26 (+86.60%) |
Jun 9, 2026 19w ago | F-1/A | $2.41 $3.64 | ▲ +51.04% | ▲ +49.59% | $1.26 (−47.72%) |
Jun 8, 2026 20w ago | 6-K | $1.28 $3.58 | ▲ +179.69% | ▲ +178.85% | $1.26 (−1.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers